Fundraising FoxNorthern Light Venture Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Immune-Onc Therapeuticsimmune-onc.cominJul 2016
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)Charlene Liao(Founder)in
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsCLI VenturesShangBay Capital LLCStartXVivo CapitalTriWise Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.